The MDM2 protein is an ubiquitin ligase that plays a critical role in regulating the levels and activity of the p53 protein, which is a central tumor suppressor. A SNP in the human MDM2 gene (SNP309 T/G) occurs at frequencies dependent on demographic history and has been shown to have important differential effects on the activity of the MDM2 and p53 proteins and to associate with altered risk for the development of several cancers. In this report, the haplotype structure of the MDM2 gene is determined by using 14 different SNPs across the gene from three different population samples: Caucasians, African Americans, and the Ashkenazi Jewish ethnic group. The results presented in this report indicate that there is a substantially reduced vari...
MDM2, a negative regulator of p53, is elevated in many cancers that retain wild-type p53. A single n...
SummaryMDM2 plays a key role in modulating p53 function. The MDM2 SNP309T > G promoter polymorphism ...
Cancer biology finds itself in a post-genomic era and the hopes of using inherited genetic variants ...
The MDM2 protein is an ubiquitin ligase that plays a critical role in regulating the levels and acti...
A large body of evidence strongly suggests that the p53 tumor suppressor pathway is central in reduc...
The MDM2 promoter SNP285C is located on the SNP309G allele. While SNP309G enhances Sp1 transcription...
The MDM2 promoter SNP285C is located on the SNP309G allele. While SNP309G enhances Sp1 transcription...
The MDM2 promoter SNP285C is located on the SNP309G allele. While SNP309G enhances Sp1 transcription...
In a recent article, a candidate pathway approach was taken to try to identify single nucleotide pol...
Cataloged from PDF version of article.The MDM2 promoter SNP285C is located on the SNP309G allele. Wh...
Since the identification of a well-characterized func-tional polymorphism named SNP309 in MDM2, abun...
The MDM2 protein, a p53 inhibitor, is involved in cell cycle control and apoptosis. MDM2 may promote...
The tumor suppressor p53 gene is mutated in minimally half of all cancers. It is therefore reasonabl...
A large body of evidence strongly suggests that the p53 tumor suppressor pathway is central in reduc...
MDM2, a negative regulator of p53, is elevated in many cancers that retain wild-type p53. A single n...
MDM2, a negative regulator of p53, is elevated in many cancers that retain wild-type p53. A single n...
SummaryMDM2 plays a key role in modulating p53 function. The MDM2 SNP309T > G promoter polymorphism ...
Cancer biology finds itself in a post-genomic era and the hopes of using inherited genetic variants ...
The MDM2 protein is an ubiquitin ligase that plays a critical role in regulating the levels and acti...
A large body of evidence strongly suggests that the p53 tumor suppressor pathway is central in reduc...
The MDM2 promoter SNP285C is located on the SNP309G allele. While SNP309G enhances Sp1 transcription...
The MDM2 promoter SNP285C is located on the SNP309G allele. While SNP309G enhances Sp1 transcription...
The MDM2 promoter SNP285C is located on the SNP309G allele. While SNP309G enhances Sp1 transcription...
In a recent article, a candidate pathway approach was taken to try to identify single nucleotide pol...
Cataloged from PDF version of article.The MDM2 promoter SNP285C is located on the SNP309G allele. Wh...
Since the identification of a well-characterized func-tional polymorphism named SNP309 in MDM2, abun...
The MDM2 protein, a p53 inhibitor, is involved in cell cycle control and apoptosis. MDM2 may promote...
The tumor suppressor p53 gene is mutated in minimally half of all cancers. It is therefore reasonabl...
A large body of evidence strongly suggests that the p53 tumor suppressor pathway is central in reduc...
MDM2, a negative regulator of p53, is elevated in many cancers that retain wild-type p53. A single n...
MDM2, a negative regulator of p53, is elevated in many cancers that retain wild-type p53. A single n...
SummaryMDM2 plays a key role in modulating p53 function. The MDM2 SNP309T > G promoter polymorphism ...
Cancer biology finds itself in a post-genomic era and the hopes of using inherited genetic variants ...